J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Handa, A.
Right arrow Articles by Brown, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Handa, A.
Right arrow Articles by Brown, K. E.
Agricola
Right arrow Articles by Handa, A.
Right arrow Articles by Brown, K. E.
Journal of General Virology (2000), 81, 2077-2084.
© 2000 Society for General Microbiology

Animal: DNA Viruses

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

Atsushi Handa1, Shin-ichi Muramatsub,1, Jianming Qiuc,1, Hiroaki Mizukamid,1 and Kevin E. Brown1

Hematology Branch, National Heart, Lung and Blood Institute, Bldg 10/Rm 7C218, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1652, USA1

Author for correspondence: Atsushi Handa. Fax +1 301 496 8396. e-mail handaa{at}nih.gov

Although adeno-associated virus (AAV)-2 has a broad tissue-host range and can transduce a wide variety of tissue types, some cells, such as erythro-megakaryoblastoid cells, are non-permissive and appear to lack the AAV-2 receptor. However, limited studies have been reported with the related dependovirus AAV-3. We have previously cloned this virus, characterized its genome and produced an infectious clone. In this study, the gene for green fluorescent protein (GFP) was inserted into AAV-2- and AAV-3-based plasmids and recombinant viruses were produced. These viruses were then used to transduce haematopoietic cells and the transduction efficiencies were compared. In contrast to recombinant (r) AAV-2, rAAV-3 successfully transduced erythroid and megakaryoblastoid cells, although rAAV-2 was superior in transduction of lymphocyte-derived cell lines. Recently, it was reported that heparan sulphate can act as a receptor of AAV-2. The infectivity of rAAV-2 and rAAV-3 was tested with mutant cell lines of Chinese hamster ovary cells that were defective for heparin or heparan sulphate expression on the cell surface. There was no correlation between the ability of rAAV-2 or rAAV-3 to infect cells and the cell surface expression of heparan sulphate and, although heparin blocked both rAAV-2 and rAAV-3 transduction, the ID50 of rAAV-3 was higher than that of rAAV-2. In addition, virus-binding overlay assays indicated that AAV-2 and AAV-3 bound different membrane proteins. These results suggest not only that there are different cellular receptors for AAV-2 and AAV-3, but that rAAV-3 vectors may be preferred for transduction of some haematopoietic cell types.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. Knappe, S. Bodevin, H.-C. Selinka, D. Spillmann, R. E. Streeck, X. S. Chen, U. Lindahl, and M. Sapp
Surface-exposed Amino Acid Residues of HPV16 L1 Protein Mediating Interaction with Cell Surface Heparan Sulfate
J. Biol. Chem., September 21, 2007; 282(38): 27913 - 27922.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
K.-Q. Xin, H. Mizukami, M. Urabe, Y. Toda, K. Shinoda, A. Yoshida, K. Oomura, Y. Kojima, M. Ichino, D. Klinman, et al.
Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells
J. Virol., December 15, 2006; 80(24): 11899 - 11910.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. Govindasamy, E. Padron, R. McKenna, N. Muzyczka, N. Kaludov, J. A. Chiorini, and M. Agbandje-McKenna
Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4
J. Virol., December 1, 2006; 80(23): 11556 - 11570.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. J. Muller, B. Leuchs, S. T. Pleger, D. Grimm, W.-M. Franz, H. A. Katus, and J. A. Kleinschmidt
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors
Cardiovasc Res, April 1, 2006; 70(1): 70 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J Adriaansen, S W Tas, P L Klarenbeek, A C Bakker, F Apparailly, G S Firestein, C Jorgensen, M J B M Vervoordeldonk, and P P Tak
Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy
Ann Rheum Dis, December 1, 2005; 64(12): 1677 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. Padron, V. Bowman, N. Kaludov, L. Govindasamy, H. Levy, P. Nick, R. McKenna, N. Muzyczka, J. A. Chiorini, T. S. Baker, et al.
Structure of Adeno-Associated Virus Type 4
J. Virol., April 15, 2005; 79(8): 5047 - 5058.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
A. Negishi, J. Chen, D. M. McCarty, R. J. Samulski, J. Liu, and R. Superfine
Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy
Glycobiology, November 1, 2004; 14(11): 969 - 977.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. E. Rabinowitz, D. E. Bowles, S. M. Faust, J. G. Ledford, S. E. Cunningham, and R. J. Samulski
Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines Subgroups
J. Virol., May 1, 2004; 78(9): 4421 - 4432.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Kern, K. Schmidt, C. Leder, O. J. Muller, C. E. Wobus, K. Bettinger, C. W. Von der Lieth, J. A. King, and J. A. Kleinschmidt
Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 Capsids
J. Virol., October 15, 2003; 77(20): 11072 - 11081.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. R. Opie, K. H. Warrington Jr., M. Agbandje-McKenna, S. Zolotukhin, and N. Muzyczka
Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding
J. Virol., June 15, 2003; 77(12): 6995 - 7006.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Xie, W. Bu, S. Bhatia, J. Hare, T. Somasundaram, A. Azzi, and M. S. Chapman
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
PNAS, August 6, 2002; 99(16): 10405 - 10410.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. U. Ried, A. Girod, K. Leike, H. Buning, and M. Hallek
Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface Receptors
J. Virol., March 27, 2002; 76(9): 4559 - 4566.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. E. Rabinowitz, F. Rolling, C. Li, H. Conrath, W. Xiao, X. Xiao, and R. J. Samulski
Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity
J. Virol., January 15, 2002; 76(2): 791 - 801.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. W. Walters, S. M. P. Yi, S. Keshavjee, K. E. Brown, M. J. Welsh, J. A. Chiorini, and J. Zabner
Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
J. Biol. Chem., June 1, 2001; 276(23): 20610 - 20616.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2000 by the Society for General Microbiology.